A detailed history of Country Trust Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Country Trust Bank holds 951 shares of ABBV stock, worth $169,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
951
Previous 951 -0.0%
Holding current value
$169,287
Previous $163,000 14.72%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $22,694 - $25,858
142 Added 17.55%
951 $173,000
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $103,475 - $116,537
-752 Reduced 48.17%
809 $125,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $166,586 - $192,848
1,247 Added 397.13%
1,561 $232,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $1,521 - $1,824
11 Added 3.63%
314 $0
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $14,517 - $18,012
-110 Reduced 26.63%
303 $49,000
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $4,575 - $5,193
-43 Reduced 9.43%
413 $45,000
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $9,258 - $10,314
-88 Reduced 16.18%
456 $51,000
Q1 2021

Apr 16, 2021

BUY
$102.3 - $112.62 $30,792 - $33,898
301 Added 123.87%
544 $59,000
Q2 2020

Jul 27, 2020

SELL
$73.37 - $98.18 $4,402 - $5,890
-60 Reduced 19.8%
243 $24,000
Q1 2020

Apr 17, 2020

SELL
$64.5 - $97.79 $67,080 - $101,701
-1,040 Reduced 77.44%
303 $23,000
Q1 2019

Apr 17, 2019

BUY
$77.14 - $90.79 $3,317 - $3,903
43 Added 3.31%
1,343 $108,000
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $119,850 - $133,236
-1,348 Reduced 50.91%
1,300 $123,000
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $84,393 - $99,856
-940 Reduced 26.2%
2,648 $245,000
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $276 - $369
-3 Reduced 0.08%
3,588 $340,000
Q4 2017

Jan 11, 2018

BUY
$89.56 - $98.21 $268 - $294
3 Added 0.08%
3,591 $347,000
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $250,621 - $320,121
3,588
3,588 $319,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.